BLF-71936-70415
4 vaccinations
6 coded responses
17 check-ins
6 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 56-60
- ZIP prefix
- 724 / AR
- Registered
- 2020-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2020-12-29
Registered in v-safe
- 2020-12-30
- 2021-01-06
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-28
- 2021-02-02
-
2021-02-09
Survey response — day 28, dose 2MedDRA: Dizziness, Nausea — Feeling: GoodFree text: Several hours of mild, but unusual dizziness and nausea that resolved spontaneously during the evening of 2/8/21.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-23
- 2021-04-15
-
2021-07-13
Survey response — 6 months, dose 2MedDRA: Upper respiratory tract infection — Feeling: GoodFree text: URI immediately after mask mandate liftedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-10-05
Dose 3 — Pfizer-BioNTech
-
2022-01-12
Survey response — 12 months, dose 2MedDRA: Intervertebral disc protrusion — Feeling: GoodFree text: Cervical HNPMedDRA releases: 2024-11 · check-in free text available
-
2022-04-29
Dose 4 — Pfizer-BioNTech
- 2022-05-08
- 2022-05-13
- 2022-05-20
- 2022-05-27
-
2022-06-05
Survey response — day 35, dose 4MedDRA: Chills, Headache, Neck pain, Pain — Feeling: GoodFree text: Body aches, heachache, neck pain without stiffness, chillsMedDRA releases: 2024-11 · check-in free text available
-
2022-07-29
Survey response — 3 months, dose 4MedDRA: COVID-19, Upper respiratory tract infection — Feeling: GoodFree text: Covid URIMedDRA releases: 2024-11 · check-in free text available
-
2022-10-28
Survey response — 6 months, dose 4MedDRA: Pre-existing disease, Vestibulitis — Feeling: GoodFree text: COVID x1 in May and x1 in June, 2022. No Paxlovid or any other medications other than naproxen. COVID-negative URI September, 2022. Mild vestibulitis for about 36 hours starting on 10/13/22 after Pfizer bivalent COVID vaccine received on 10/12/22.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-05 | Pfizer-BioNTech | No |
| 4 | 2022-04-29 | Pfizer-BioNTech | No |
Free text
Release 3 — day 28, dose 2
Symptoms: Several hours of mild, but unusual dizziness and nausea that resolved spontaneously during the evening of 2/8/21.
Release 9 — 6 months, dose 2
Symptoms: URI immediately after mask mandate lifted
Release 10 — 12 months, dose 2
Symptoms: Cervical HNP
Release 11 — day 35, dose 4
Symptoms: Body aches, heachache, neck pain without stiffness, chills
Release 12 — 3 months, dose 4
Symptoms: Covid URI
Release 12 — 6 months, dose 4
Symptoms: COVID x1 in May and x1 in June, 2022. No Paxlovid or any other medications other than naproxen. COVID-negative URI September, 2022. Mild vestibulitis for about 36 hours starting on 10/13/22 after Pfizer bivalent COVID vaccine received on 10/12/22.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Intervertebral disc protrusion | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Neck pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SD | Vestibulitis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release